Boston University
Gastric oxidative status as a predictor of inflammation and symptom severity in pediatric patients with suspected gastroesophageal reflux disease
Abstract
dc:description.abstractINTRODUCTION: Gastroesophageal reflux disease (GERD) is a chronic disorder characterized by the inappropriate movement of gastric contents back into the esophagus. In pediatric patients, this can present as symptoms of heartburn, chest pain, and difficulty swallowing (dysphagia). While pH monitoring and endoscopic evaluation are standard diagnostic tools for evaluating children and young adults with suspected GERD, the gross and histological findings do not uniformly correlate with symptom severity or predict disease progression. Emerging evidence suggests that oxidative stress plays a role in mucosal inflammation and symptom development in the upper gastrointestinal tract. Oxidative stress occurs when there is an imbalance between reactive oxygen and nitrogen species (RONS) and the body’s antioxidant defenses, leading to cellular damage and inflammation. Assessing gastric redox status through direct measurement of the oxidative-reductive potential (ORP) of gastric fluid samples may serve as a novel, non-invasive biomarker for assessing disease activity and monitoring response to therapy in pediatric patients with known or suspected gastroesophageal reflux disease. OBJECTIVES: This study aims to explore the relationship between gastric oxidative status and disease symptom severity in pediatric patients with suspected gastroesophageal disease. A secondary aim of this study is to assess the impact of proton pump inhibitor (PPI) therapy on gastric redox status. METHODS: We recruited pediatric and young adult patients (ages 2-21) in the Gastrointestinal Procedural Unit (GPU) at Boston Children’s Hospital who were undergoing evaluation for gastroesophageal symptoms, including reflux and dyspepsia. Aspirated gastric fluid samples were collected, and the oxidation-reduction potential (ORP) and pH were analyzed in real time using commercially available redox (Mettler-Toledo) and pH sticks. Samples were collected between July 2024 and March 2025. RESULTS: Data analysis demonstrated that measuring the ORP of gastric aspirate fluid collected from endoscopic evaluation may be a useful biomarker for assessing disease activity and targeting therapeutic strategies in pediatric patients with known or suspected reflux. A moderate negative correlation was observed between gastric redox potential and pH (R2 = 0.44). Patients with biopsy-confirmed mucosal inflammation (n = 20) showed a higher median ORP compared to those without inflammation (n = 28); however, the difference was not statistically significant (p = 0.18). Analysis of PPI and H2-blocker therapy revealed no significant impact on gastric redox status (ANOVA, p = 0.28). CONCLUSION: The measurement of ORP in the gastric aspirate fluid of patients with known or suspected reflux may be a reliable indicator of disease severity and a target for therapeutic strategies aimed at improving symptom management. Future studies will focus on increasing patient recruitment and study population to more definitively assess the relationship between gastric oxidative status and disease activity in patients with GER or GERD. Furthermore, real-time measurement techniques are also warranted to validate ORP measurements as a clinical biomarker in pediatric gastrointestinal disease.
Degree
thesis:*- Name thesis:degree_name
- Master of Science
- Level thesis:degree_level
- masters
- Discipline thesis:degree_discipline
- Medical Sciences
- Grantor
- Boston University
- Year dc:date.issued
- 2025
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Rahman, Thusme
- Advisors dc:contributor.advisor
-
- Herscovitz, Haya
- Rufo, Paul A.
Subjects
dc:subject × 1Rights
- Language dc:language.iso
- en_US
Identifiers
dc:identifier.*- Handle dc:identifier.uri
- https://hdl.handle.net/2144/53205